Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider for the Company's Preferred Share

MARKN.

Chordate Medical Holding AB (publ) ("Chordate" or the "Company") has entered into a liquidity provider agreement for the Company's preferred share with Lago Kapital ("Lago").

Under the agreement, Lago will place bid and ask orders in Chordate's preferred share in accordance with and within the framework of Nasdaq Stockholm's regulations for liquidity provision. The purpose of the liquidity provider arrangement is to improve liquidity and reduce volatility. Lago's assignment will commence on March 17, 2025.

Datum 2025-03-17, kl 08:25
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!